MAPT and Alzheimer disease: Compared to CSF Aβ, tau may correlate better with hippocampal atrophy, as suggested by previous volumetric studies in symptomatic stages of AD (Henneman et al., 2009; Apostolova et al., 2010; de Souza et al., 2012).